MedTrace Logo

Duloxetine Role in Reducing Opioid Consumption After Thoracotomy

NCT03618225 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-10-14

No results posted yet for this study

Summary

A total of 60 patients scheduled for thoracotomy with the aim of excision of pleural or lung cancer, will be randomized by the use of a computer-generated table of random numbers to receive duloxetine 60 mg orally 2 hours before the surgical procedure and at 24 hours after the surgical procedure or a placebo pill following the same time schedule.

Conditions

  • Post-thoracotomy Pain

Interventions

DRUG

Oral Duloxetine 60mg

duloxetine 60 mg orally 2 hours before the surgical procedure and at 24 hours after the surgical procedure

DRUG

placebo pill

placebo pill orally 2 hours before the surgical procedure and at 24 hours after the surgical procedure

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-15
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03618225 on ClinicalTrials.gov